Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution

Bioconjugate Chemistry

Volumn 10, Issue 3, 1999, Pages 338-345

  Tolmachev, Vladimir ^a,c   Koziorowski, Jacek ^a,d   Sivaev, Igor ^b   Lundqvist, Hans ^a   Carlsson, Jörgen ^a   Orlova, Anna ^a   Gedda, Lars ^a   Olsson, Pär ^a   Sjöberg, Stefan ^a   Sundin, Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b A N NESMEYANOV INSTITUTE OF ORGANOELEMENT COMPOUNDS   (Russian Federation)

^c KURCHATOV INSTITUTE   (Russian Federation)

^d PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHEMICAL BONDS; PROTEINS;

ACIDIC MEDIA; BIODISTRIBUTIONS; BORON-CONTAINING; CARBON-HALOGEN BOND; CHLORAMINE-T; CONJUGATION CHEMISTRY; DOUBLE BONDS; HALOGEN BONDS; IN-VIVO; RADIOACTIVE LABELLING;

DEGRADATION;

ANIMALIA;

EID: 0033136664     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc980033s     Document Type: Article

References (62)

1. Ali, S. A., Warren, S. D., Richter, K. Y., Badger, C. C., Eary, J. F., Press, O. W., Krohn, K. A., Bernstein, I. D., and Nelp, W. B. (1990) Improving of the retention of radioiodinated antibody: aryl carbohydrate adducts. Cancer Res. 50, 783-788.
2. Andersson, A., Holmberg, A., Carlsson, J., Carlsson, J., Ponten, J., and Westermark, B. (1991) Binding of epidermal growth factor-dextran conjugates to cultured glioma cells. Int. J. Cancer 47, 439-444.
3. 131I conjugates on the clonogenic survival of cultured glioma cells. J. Neuro-Oncology 14, 213-223.
4. Arbit, E., Cheung, N. K., Yeh, S. D., Daghighian, F., Zhang, J. J., Cordon-Cardo, C., Pentlow, K., Canete, A, Finn, R., and Larson, S. M. (1995) Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumours. Eur. J. Nucl. Med. 22, 419.
5. Behr, T. M., Goldenberg, D. M., and Becker, W. (1998) Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnostics and therapy: present status, future prospects and limitations. Eur. J. Nucl. Med. 25, 201-212.
6. Bernard, B. F., Krenning, E. P., Breeman, W. A., Rolleman, E. J., Bakker, W. H., Visser, T. J., Macke, H., and de Jong, M. (1997) D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J. Nucl. Med. 38, 1929-1933.
7. Bischof-Delaloye, A., Delaloye, B., Buchegger, F., von Fieldner, V., Gilgien, W., Studer, A., Curchod, S., Moisman, F., Pettavel, J., and Mach, J.-P. (1989) Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study. J. Nucl. Med. 30, 1646-1656.
8. Bischof-Delaloye, A., Delaloye, B., Buchegger, F., Vogel, C.-A., Gillet, M., Mach, J.-P., Smith, A., and Schubiger, P. A. (1997) Comparison of copper-67 and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors. J. Nucl. Med. 38, 847-853.
9. Carlsson, J., Gedda, L., Grönvik, C., Hartman, T., Lindstrom, A., Lindstrom, P., Lundqvist, H., Lovqvist, A., Malmqvist, J., and Olsson, P. (1994) Strategy for boron neutron capture therapy against tumor cells with overexpression of the epidermal growth factor receptor. Int. J. Radiat. Oncol. Biol. Phys. 30, 105-115.
10. Carnochan, P., Trivedi, M., Young, H., Eccles, S., Potter, G., Haynes, B., and Ott, R. (1994) Biodistribution and kinetics of radiolabeled pyrrolidino-4-iodo-tamoxifen: prospects for pharmacokinetic studies using PET. J. Nucl. Biol. Med. 38, 96.
11. Christensen, E. I., and Maunsbach, A. B. (1981) Dextran is resistant to lysosomal digestion in kidney tubules. Virchows Arch. (Cell Pathol.) 37, 49-59.
12. Cleeland, R., Christenson, J, Usategui-Gomez, M., Heveran, J., Davis, R., and Grunberg, E. (1976) Detection of drugs of abuse by radioimmunoassay: a summary of published data and some new information. Clin. Chem. 22, 712-725.
13. 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur. J. Nucl. Med. 22, 608-616.
14. 3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Int. J. Cancer. 75, 406-411.
15. 123I-labeled Fab or F(ab′)2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J. Clin. Invest. 77, 301-311.
16. Dewanjee, M. K. (1992) Radioiodination: theory, practice, and biomedical applications; Kluwer academic publishers: Boston, MA.
17. Duncan, J. R., and Welch, M. J. (1993) Intracellular metabolism of indium-111-DTPA labeled receptor targeted proteins. J. Nucl. Med. 34, 1728-1738.
18. Garg, S., Garg, P. K., and Zalutsky, M. H. (1991) N-succinimidyl-5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination. Bioconjugate Chem. 2, 50-56.
19. Garg, S., Garg, P. K., and Zalutsky, M. H. (1993) N-succinimidyl-4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies. Nucl. Med. Biol. 20, 379-387.
20. Gasparini, M., Buraggi, G. L., Regalia, E., Maffioli, L., Balzarini, L., and Gennari L. (1994) Comparison of radioimmunodetection with other imaging methods in evaluating local relapses of colorectal carcinoma. Cancer 73, 864-849.
21. Gedda, L., Olsson, P., Ponten, J., and Carlsson, J. (1996) Development and in vitro studies of epidermal growth factor-dextran conjugates for boron-neutron capture therapy. Bioconjugate Chem. 7, 584-591.
22. Geissler, F., Anderson, S. K., Venkatesan, P., and Press, O. (1992) Intracellular catabolism of radiolabeled anti-μ antibodies by malignant B-cells. Cancer Res. 52, 2907-2915.
23. 11X]; X = Cl, Br, I. Z. Anorg. Allg. Chem. 621, 1454-1458.
24. Holmberg, A., and Meurling, L. (1993) Preparation of sulfhydrylborane-dextran conjugates for boron neutron capture therapy. Bioconjugate Chem. 4, 570-573.
25. 99mTc. Antibody Immunoconj. Radiopharm. 7, 149-154.
26. Holmberg, A., Marquez, M., Westlin, J.-E., and Nilsson, S. (1994b). Preparation, in vitro binding and technetium-99m labeling of somatostatin-dextran conjugates. Antibody Immunoconj. Radiopharm. 7, 253-259.
27. Kerr, J. A. (1992) Strengths of chemical bonds. in Handbook of chemistry and physics, 72nd ed. (D. R. Lide, Ed.) pp 9-105 to 9-113, CRC press, Boca Raton, FL.
28. Khaw, B. A., Cooney, J., Edingtom, T., and Strauss, H. W. (1986) Differences in experimental tumor localisation of dual-labeled monoclonal antibody. J. Nucl. Med. 27, 1293-1299.
29. 123I-N-isopropyl-p-iodoamphetamine with single-photon emission computed tomography in the diagnosis of stroke and Alzheimer's disease. Nucl. Med. Commun. 10, 271-284.
30. Knight, L. C., and Welch, M. J. (1978) Sites of direct and indirect halogenation of albumin. Biochim. Biophys. Acta 534, 185-195.
31. 122-. Inorg. Chem. 3, 159-167.
32. Knox, S. J. (1995) Overview of studies on experimental radioimmunotherapy. Cancer Res. (Suppl.) 55, 5832s-5836s.
33. Kulkarni, P. V., and Corbett, J. R. (1990) Radioiodinated tracers for myocardial imaging. Semin. Nucl. Med. 20, 119-129.
34. Kusic, Z., Becker, D. V., Saenger, E. L., Paras, P., Gartside, P., Wessler, T., and Spaventi, S.(1990) Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathologic findings. J. Nucl. Med. 31, 393-399.
35. Larson, S. M., and Carrasquillo, J. A. (1988) Advantages of radioiodine over radioindium labeled monoclonal antibodies for imaging solid tumors. Nucl. Med. Biol. 15, 231-233.
36. 131I monoclonal antibodies in the therapy of leptomengial tumors. Cancer 61, 857-868.
37. Lindström, A., and Carlsson, J. (1993) Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin. Cancer Biother. 8, 145-158.
38. Lövqvist, A., Lindström, A., and Carlsson, J. (1993) Binding, internalisation and excretion of TGF-alfa-dextran associated radioactivity in cultured human glioma cells. Cancer Biother. 8, 345-356.
39. Meijs, W. E., Haisma, H. J., Klok, R. P., van Gog, F. B., Kievit, E., Pinedo, H. M., and Herscheid, J. D. M. (1997) Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice. J. Nucl. Med. 38, 112-118.
40. Molteni, L. (1979) Dextrans as drug carriers, in Drug carriers in biology and medicine (G. Gregoriadis, Ed.) pp 107-125, Academic Press, London.
41. Mowry, R. W., and Nillican, R. C. (1953) A histological study of the distribution and fate of dextran in tissue of the mouse. Am. J. Pathol. 29, 523-545.
42. Nishikawa, M., Yamashita, F., Takakura, Y., Hashida, M., and Sezaki, H. (1992) Demonstration of the receptor-mediated hepatic uptake of dextran in mice. J. Pharm. Pharmocol. 44, 396-401.
43. O'Doherty, M. J., Nunan, T. O., and Croft, D. N. (1993) Radionuclides and therapy of thyroid cancer. Nucl. Med. Commun. 14, 736-755.
44. Olsson, P., Lindström, A., and Carlsson, J. (1994) Internalization and excretion of epidermal growth factor-dextran associated radioactivity in cultured human squamous-carcinoma cells. Int. J. Cancer 56, 529-537.
45. Press, O. W., Shan, D., Howell-Clark, J., Eary, J., Appelbaum, F. R., Metthews, D., King, D. J., Haines, M. R., Hamann, P., Hinman, L., Shochat, D., and Bernstein, I. D. (1996) Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. Cancer Res. 56, 2123-2129.
46. Reist, G. J., Archer, G. E., Kurpad, S. N., Wikstrand, C. J., Vaidyanathan, G., Willingham, M. C., Moscatello, D. K., Wong, A. J., Bigner, D. D., and Zalutsky, M. R. (1995) Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts. Cancer Res. 55, 4375-4382.
47. Ryser, J. E., Jones, R. M., Egeli, R., Pelegrin, A., Rose, K., Kurt, A. M., Perin, M., Broquet, P. E., Ambrosetti, P., Fisch, I., Pochon, S., Donath, A., Mach, J. P., and Offord, R. E. (1992) Colon carcinoma immunoscintigraphy by monoclonal anti-CEA antibody labeled with gallium-67-aminooxyacetyldeferroxamine. J. Nucl. Med. 33, 1766-1773
48. Schott, M. E., Milenic, D. E., Yokota, T., Whitlow, M., Wood, J. F., Fordyce, W. A., Cheng, R. C.; Schlom, J. (1992) Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules. Cancer Res 52 6413-6417.
49. 125I-labeled polypeptide, Epidermal growth factor. Nucl. Med. Biol. 18, 241-246.
50. 2-; X = Cl, n = 1-3; X = Br, n = 1, 2; X = I, n = 1. Z. Naturforsch., Teil B. Chem. Sci. 39, 189-196.
51. Stein, R., Goldenberg, D. M., Thorpe, S. R., and Mattes, M. J. (1997) Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human nonsmall-cell carcinoma of the lung. J. Nucl. Med. 38, 391-395.
52. Todderud, G., and Carpenter, G. (1989) Epidermal growth factor: the receptor and its function. BioFactors 2, 11-15.
53. 131I-MIBG therapy of neural crest tumours (review). Anticancer Res. 17, 1823-1831.
54. Wilbur, D. S. (1992) Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjugate Chem. 3, 433-470.
55. Wilbur, D. S., Hadley, S. W., Hylarides, M. D., Abrams, P. G., Beaumier, P. A., Morgan, A. C., Reno, J. M., and Fritzberg, A. R. (1989) Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J. Nucl. Med. 39, 216-226.
56. Wilbur, D. S., Hamlin, D. K., Buhler, K. R., Srivastava, R. R., Stray, J. E., Daniel, J., and Vessela, R. J. (1995) Comparison of in vivo distributions of simple radioiodinated borane and carborane cage molecules. Q. J. Nucl. Med. 39, 51-52.
57. Young, H., Carnochan, P., Trivedi, M., Potter, G. A., Eccles, S. A., Haynes, B. P., Jarman, M., and Ott, R. J. (1995) Pharmacokinetics and biodistribution of radiolabeled idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapy. Nucl. Med. Biol. 22, 405-411.
58. Zalutsky, M. R (1988). Radiohalogenation of antibodies: chemical aspects, in Radiolabeled monoclonal antibodies for imaging and therapy (S. C. Srivastava, Ed.) pp 195-214, Plenum Press, New York.
59. Zalutsky, M. R., and Narula, A. S. (1987) A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine. Appl. Radiat. Isot. 38, 1051-1055.
60. Zalutsky, M. R., and Narula, A. S. (1988) Radiohalogenation of a monoclonal antibody using an N-succinimidyl-3-(tri-n-butylstanny)benzoate intermediate. Cancer Res. 48, 1446-1450.
61. Zalutsky, M. R., Noska, M. A., Colapinto, E. V., Garg, P. K., and Bigner, D. D. (1989) Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate. Cancer Res. 49, 5543-5549.
62. Zhao, Q., Blomquist, E., Bolander, H., Gedda, L., Hartvig, P., Jahnson, J.-K., Lundquist, H., Mellstedt, H., Nilsson, S., Nister, M., Sundin, A., Tolmachev, V., Westlin, J.-E., and Carlsson, J. (1998) Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine. Preclinical tests in preparation for clinical trials. Int. J. Mol. Med. 1, 693-702.